Home
Products
API
FDF
Intermediate
CRO
About Us
Company Profile
Service
Resources
R&D
Research Institute
Solution
Quality System
News
Company News
Industry News
Contact Us
English
English
العربية
Français
Pусский
Español
Português
Email
Follow
Search
close
Choose Your Site
Global
Social Media
Home
Products
API
FDF
Intermediate
CRO
About Us
Company Profile
Service
Resources
R&D
Research Institute
Solution
Quality System
News
Company News
Industry News
Contact Us
Erlotinib Hydrochloride Tablet
You are here:
Home
»
Products
»
Finished Preparation
»
Anti-cancer Drugs
»
Erlotinib Hydrochloride Tablet
Home
Contact Us
:
All
Product Name
Product Keyword
Product Model
Product Summary
Product Description
Multi Field Search
Product Category
API
Analgesic APIS
Parecoxib Sodium
Anti Allergic APIS
Desloratadine
Anti-cancer APIS
Sorafenib Tosylate
Lenvatinib Mesilate
Pazopanib Hydrochloride
Daprodustat
Osimertinib Mesylate
Darolutamide
Relugolix
Abemaciclib
Erlotinib HCl
Dacomitinib
Sunitinib Malate
Gefitinib
Anamorelin HCl
Niraparib Tosylate
Anti Gout APIS
Topiroxostat
Dotinurad
Anti-inflammatory APIS
Pranoprofen
Cardiovascular APIS
Levosimendan
Vericiguat
Rosuvastatin Calcium
Olprinone HCl
Lanthanum Carbonate
Ezetimibe
Nafamostate Mesylate
Prasugrel Hydrochloride
Azilsartan Medoxomil Potassium
Digestive System APIS
Ilaprazole
Endocrine APIS
Ertugliflozin
Empagliflozin
Linagliptin
Prucalopride Succinate
Vildagliptin
Naldemedine Tosylate
Elagolix Sodium
Fezolinetant
Linzagolix
Resmetirom
Hormones APIS
Finerenone
Hypoglycemic APIS
Sitagliptin Phosphate Monohydrate
Immunomodulatory APIs
Upadacitinib
Apremilast
Nerandomilast
Local Anesthetic APIS
Levobupivacaine HCl
Mental Nerves APIS
Atomoxetine HCl
Vortioxetine Hydrobromide
Perampanel
Lacosamide
Reproductive System APIS
Dapoxetine HCl
Vardenafil HCl
Silodosin
Respiratory System APIS
Gefapixant Citrate
Revefenacin
Smoking Cessation APIS
Varenicline Tartrate
Stomach APIS
Vonoprazan Fumarate
Fexuprazan Hydrochloride
Urinary System APIS
Mirabegron
Finished Preparation
Anti-cancer Drugs
Erlotinib Hydrochloride Tablet
Sunitinib Malate Capsule
Antidiabetic Drugs
Empagliflozin Tablet
Vildagliptin Tablet
Anti Gout Drugs
Etoricoxib Tablet
Febuxostat Tablet
Antiviral Drugs
Lamivudine Tablet
Mental Nerves Drugs
Gabapentin Capsule
Pregabalin Oral Solution
Lacosamide Tablet
Lacosamide Oral Solution
Aripiprazole Oral Solution
Levetiracetam Oral Solution
Risperidone Oral Solution
Smoking Cessation Drugs
Varenicline Tartrate Tablet
Urinary System Drugs
Dapoxetine HCl Tablet
Volume Expansion Drugs
Calcium Acetate Oral Solution
APIs, FDFs, & Intermediates
Erlotinib Hydrochloride Tablet, part of Loncom Pharma's Anti-cancer Drugs, is a critical component in the fight against cancer. It targets specific pathways, offering hope to cancer patients and improving their quality of life.
Erlotinib Hydrochloride Tablet
Inquire
Add to Basket
More >>
Name
Size
Update
Download
Biocom/Loncom FDF Product List.pdf
991KB
2026-04-14
Download
Biocom/Loncom API Product List.pdf
903KB
2026-04-14
Download
Loncom Intermediate List.pdf
4.69MB
2026-01-22
Download
info@loncompharm.com
Tel: +86-531-87626506
Tel: +86-531-88114068
Tel: +86-531-88114952
Tel: +86-531-88285356
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong, China
QUICK LINKS
Home
Products
About Us
R&D
Quality System
News
Contact Us
PRODUCT CATEGORY
API
Finished Preparation
Intermediate
Copyright ©
2023
Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved.
Sitemap
|
Privacy Policy
Supported by
leadong.com
Contact Us
Submit
